Product Information

GNP DUAL ACTION PAIN 250-125 MG is a generic product labeled by AmerisourceBergen, priced at $0.0890 per EA under NDC 46122081861. Its NADAC has been published 61 times since Sep 24, 2025.

FDA first approved this application on Aug 1, 2023.

GNP DUAL ACTION PAIN 250-125 MG

Acetaminophen and Ibuprofen
$0.0890per EA
OTC

Strength

250; 125 mg/1; mg/1

Manufacturer

AmerisourceBergen

NDC

46122081861

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ACETAMINOPHEN; IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA216999

FDA Approved

8/1/2023

On Market Since

5/15/2025

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for GNP DUAL ACTION PAIN 250-125 MG has been published 61 times since Sep 24, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0890 per EA
All-time high$0.1071 (Oct 14, 2026)
All-time low$0.0839 (Apr 22, 2026)
52-week high$0.1071
52-week low$0.0839
Median price$0.0905
Average price$0.0932
Largest weekly change-12.8% (Oct 21, 2026)
Weeks tracked61
Tracking sinceSep 24, 2025

Price History

1W

-4.6%

1M

-4.6%

3M

-15.9%

6M

+5.5%

1Y

-4.8%

3Y

N/A

5Y

N/A

All

-0.2%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GNP DUAL ACTION PAIN 250-125 MG?

The current National Average Drug Acquisition Cost (NADAC) for GNP DUAL ACTION PAIN 250-125 MG, manufactured by AmerisourceBergen, is $0.0890 per EA (NDC 46122081861), effective Nov 18, 2026.

How has the price of GNP DUAL ACTION PAIN 250-125 MG changed over time?

Over the history we have for it, the NADAC for GNP DUAL ACTION PAIN 250-125 MG has held within roughly two percent of its current level. It has been tracked across 61 weekly CMS publications since Sep 24, 2025.

What are the highest and lowest recorded NADAC prices for GNP DUAL ACTION PAIN 250-125 MG?

Since Sep 24, 2025, the NADAC for GNP DUAL ACTION PAIN 250-125 MG has ranged from a low of $0.0839 (Apr 22, 2026) to a high of $0.1071 (Oct 14, 2026), with a median of $0.0905 per EA.

Are there cheaper alternatives to GNP DUAL ACTION PAIN 250-125 MG?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACETAMINOPHEN-IBUPROFEN 250-125 MG CAPLET, is $0.0844 per EA — about 5% below GNP DUAL ACTION PAIN 250-125 MG.

Who manufactures GNP DUAL ACTION PAIN 250-125 MG?

GNP DUAL ACTION PAIN 250-125 MG (NDC 46122081861) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.